Enviva Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Glenn T. Nunziata
- Full Time Employees
- 1,234
- Sector
- Basic Materials
- Industry
- Paper, Lumber & Forest Products
- Address
- 7272 Wisconsin Avenue Bethesda MD United States of America 20814
- IPO Date
- Apr 29, 2015
- CIK
- 0001592057
- Website
- envivabiomass.com
- Similar Companies
- Business
- Enviva Inc. (EVVAQ) produces, processes, supplies and sells utility-grade industrial wood pellets as a renewable and sustainable alternative to fossil fuels for power generation and industrial applications including steel, cement, lime, chemicals and aviation fuels; the company develops, constructs, acquires, owns and operates wood pellet production plants; it aggregates wood fiber from the U.S. Southeast, processes it into energy-dense, low-moisture pellets and exports primarily through deep-water marine terminals at the Port of Chesapeake, Virginia, Port of Wilmington, North Carolina, Port of Pascagoula, Mississippi and third-party terminals in Savannah, Georgia, Mobile, Alabama and Panama City, Florida. Enviva serves power generators and industrial customers in the United Kingdom, European Union and Japan under long-term take-or-pay offtake contracts. Founded in 2004 and headquartered in Bethesda, Maryland, the company owns and operates ten plants across Virginia, North Carolina, South Carolina, Georgia, Florida and Mississippi with annual production capacity of approximately 5.0 million metric tons; it is completing construction of its eleventh plant in Epes, Alabama, expected to add 1.1 million metric tons per year and produce first pellets in May 2025. Enviva, formerly Enviva Partners LP, changed its name to Enviva Inc. in December 2021; it filed for Chapter 11 bankruptcy reorganization in March 2024 and emerged successfully in December 2024 after equitizing over $1 billion in debt, securing $250 million in new equity financing via a rights offering backed by American Industrial Partners Capital Fund as the largest shareholder, and obtaining an exit loan facility with delayed draw term loan access to fund operations, growth and the Epes plant ramp-up, resulting in no near-term debt maturities and enhanced liquidity.
EVA LIVE TARGETS A $3 TRILLION GLOBAL DEFENSE, SATELLITE AND AI INFRASTRUCTURE OPPORTUNITY WITH PROPOSED ACQUISITION OF AIRBEAM WIRELESS TECHNOLOGIES
Willis Lease Finance Corporation Acquires Three Airbus A330-300 Aircraft That Will Be Leased to China Airlines and EVA Air
EVA Live Increases Ownership Interest to 51% in Spiro Senior Living Following Successful Launch of Initial Healthcare and Technology Operations Tapping 1.3 Trillion Dollar Industry
EVA Live launches FastQuoteDirect, it's AI-Powered Consumer Engagement Platform Across 5.6 Billion Dollar Market
EVA Live Targets the $1.3 Trillion Senior Care Industry Through Strategic Partnership with Spiro Senior
EVA Live Inc.'s Revenues Surge 82.6% to $17M as Company Swings to $8.1M Net Income
EVA Live Secures Strategic Growth Financing to Accelerate AI Platform Expansion as Part of 2026 Growth Strategy
EVA Live Announces Fast Quote Direct™ — A Disruptive AI Quoting Engine Targeting the Online Lead Generation Industry
EVA Live Launches Interactive B2B Web Application to Support Rapid Growth and Client Acquisition
EVA Live CEO Signals Confidence as Company Focuses on Disciplined Growth
EVA Live Launches NeuroServe, Its Next-Generation AI Online Advertising Platform
EVA Air and Southwest Airlines Launch Interline Partnership to Expand Seamless Travel Between Asia and North America
NEW PLACES, NEW PARTNER: SOUTHWEST SETS SIGHTS ON ST. MAARTEN AND BEGINS NEW RELATIONSHIP WITH EVA AIR
Livestock Identification Company Evaluation Report 2025 | Merck, Shearwell, Datamars Drive Innovations with Comprehensive Tagging and Tracking Solutions
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Green Thumb: Consistent Growth, Positive EVA, And Bullish Outlook, Buy
Taiwan's EVA Air activates NDC connection with Sabre
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
EVA Orders GEnx Engines to Power Boeing 787 Fleet Expansion